Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on April 11, 2002

Arteriosclerosis, Thrombosis, and Vascular Biology. 2002
Published online before print April 11, 2002, doi: 10.1161/01.ATV.0000018306.68268.86
A more recent version of this article appeared on June 1, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/6/1029    most recent
01.ATV.0000018306.68268.86v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneider, N. C.
Right arrow Articles by Wiedermann, C. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kaneider, N. C.
Right arrow Articles by Wiedermann, C. J.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Thrombin
Right arrow Platelet function inhibitors
Right arrow Platelets

Submitted on February 24, 2002
Accepted on March 22, 2002

Rho-GTPase--Dependent Platelet-Neutrophil Interaction Affected by HMG-CoA Reductase Inhibition With Altered Adenosine Nucleotide Release and Function

Nicole C. Kaneider ; Petra Egger ; Stefan Dunzendorfer ; and Christian J. Wiedermann *

From the Division of General Internal Medicine, Department of Internal Medicine, University of Innsbruck, Innsbruck, Austria.

* To whom correspondence should be addressed. E-mail: Christian.Wiedermann{at}uibk.ac.at.

Abstract—Platelet activation and aggregation is considered a crucial step in the initiation and aggravation of arterial thrombosis. ADP from activated platelets is recognized as major factor in thrombus formation and is a potent stimulator of oxygen-free radical release from neutrophils. The aim of the present investigation was to determine in vitro the direct effects of statins on ATP and ADP secretion by platelets and its impact on subsequent oxidative burst activity in neutrophils. Human neutrophils and platelets were isolated from peripheral blood. Levels of platelet-derived ATP and ADP were measured by high-performance liquid chromatography, oxygen-free radical release of neutrophils was measured fluorometrically, and chemotaxis experiments were performed. Rho-GTPases were studied by Western blot analysis. Thrombin-activated platelets primed neutrophils for enhanced oxygen-free radical release on triggering with formyl-Met-Leu-Phe, reduced by cerivastatin and simvastatin treatment of platelets. The two statins decreased the amount of adenosine-derivative release in these cells. Rho-GTPases, required for the thrombin signaling in platelets and neutrophils, were decreased after coincubation with statins. Data demonstrate that inhibition of Rho-GTPases by statins inhibit platelet ADP and ATP release and the consecutive augmentation of neutrophil oxygen-free radical release. Statins affect platelet-neutrophil interactions by altering Rho-GTPase--dependent adenosine nucleotide function.






ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.